Delivery Order SPE2DB22D3016-SPE2DB25FAYH9
Award Date
6/4/25
Potential Completion Date
6/5/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $2,525.95 and a completion date of May 29, 2025. The contract is a firm-fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $2,437.75 and a completion date of May 15, 2025. The contract is a firm fixed-price, non-set-aside vehicle, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The delivery order has a ceiling value of $2,408.19 and a completion date of May 30, 2025. The contract is a firm fixed price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $2,178.99 and a performance period through May 13, 2025. The contract is a firm fixed-price delivery order and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $4,211.73 and a completion date of June 16, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $1,397.18. The contract is a firm fixed price, non-set-aside award with a period of performance through May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The contract is a firm fixed-price delivery order with a ceiling value of $5,623.20 and a completion date of May 21, 2025. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of diabetes medication, with a ceiling value of $1,840.22 and a performance period ending on June 9, 2025. The contract is a Firm Fixed Price delivery order, which means the price is set and not subject to adjustment. This award is not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $5,103.49 and a period of performance through May 30, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The contract has a ceiling value of $1,543.08 and is a Firm Fixed Price contract. The period of performance extends through June 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...